Cleared Traditional

K040932 - EASYNET BODY POSITION MODULE

K040932 is an FDA 510(k) clearance for EASYNET BODY POSITION MODULE, manufactured by Cadwell Laboratories, Inc.. The device is a Class 2 Neurology device with product code LEL cleared through the Traditional 510(k) pathway after a 83-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2004
Decision
83d
Days
Class 2
Risk

K040932 is an FDA 510(k) clearance for the EASYNET BODY POSITION MODULE. Classified as Device, Sleep Assessment (product code LEL), Class II - Special Controls.

Submitted by Cadwell Laboratories, Inc. (Kennewick, US). The FDA issued a Cleared decision on July 1, 2004 after a review of 83 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cadwell Laboratories, Inc. devices

FDA 510(k) Submission Details - K040932

510(k) Number K040932 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 09, 2004
Decision Date July 01, 2004
Days to Decision 83 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 148d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LEL Device Classification - Class 2, Special Controls

Product Code LEL Device, Sleep Assessment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - LEL Device, Sleep Assessment

All 9
Devices cleared under the same product code (LEL) and FDA review panel - the closest regulatory comparables to K040932.
Oxevision Sleep Device
K233618 · Oxehealth Limited · Apr 2024
ActiGraph LEAP activity monitor (ActiGraph LEAP)
K231532 · Actigraph, LLC · Jun 2023
ActiGraph CentrePoint Insight Watch
K181077 · Actigraph · May 2018
CADWELL LIMB MOVEMENT MODULE
K040986 · Cadwell Laboratories, Inc. · Jul 2004
REMVIEW SLEEP RECORDER, MODEL 320
K003499 · Respironics, Inc. · Feb 2001